Study summary

Clinical study to examine the safety, tolerability and efficacy of long-term combination therapy of tamsulosin and solifenacin in the treatment of males with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) with a substantial storage component.

Additional Study Details

Phase
3
Product
N/A
Product
tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg)
tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg)
Type
Interventional
Masking
None (Open Label)
Enrollment number
1067
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for Long term study of solifenacin succinate and tamsulosin hydrochloride Oral Controlled Absorption System (OCAS) in males with lower urinary tract symptoms? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Withdrawn
    Moscow, Russian Federation, 105425
    Withdrawn
    Portogruaro, Italy, 300026
    Withdrawn
    Moscow, Russian Federation, 125206
    Completed
    Treviglio, Italy, 24047
    Completed
    Koblenz, Germany, 56068
    Completed
    Minsk, Belarus, 220119
    Completed
    Frankfurt, Germany, 65933
    Completed
    Sachsen, Germany, 06526
    Withdrawn
    Paris Cedex 14, France, 75679
    Completed
    Krakow, Poland, 31-530
    Withdrawn
    Turin, Italy, 10126
    Completed
    Vienna, Austria, 1090
    Completed
    Bautzen, Germany, 02625
    Withdrawn
    St. Petersburg, Russian Federation, 198013
    Withdrawn
    Salzburg, Austria, 5020
    Completed
    Colmar Cedex, France, 68024
    Withdrawn
    Aix en Provence, France, 13616
    Completed
    Piestany, Slovakia, 921 02
    Withdrawn
    Palermo, Italy, 90146
    Completed
    Trier, Germany, 54290
    Completed
    Neustadt in Sachsen, Germany, 01844
    Completed
    Avellino, Italy, 83100
    Completed
    Cardiff, United Kingdom, CF14 5GJ
    Completed
    Innsbruck, Austria, 6020
    Withdrawn
    Brussels, Belgium, 1200
    Completed
    Bielsko-Biala, Poland, 43-300
    Completed
    Liege 1, Belgium, 4000
    Completed
    Winterswijk, Netherlands, 7101 BN
    Completed
    Paris, France, 75010
    Withdrawn
    Creteil Cedex, France, 94010
    Completed
    Hagenow, Germany, 19230
    Withdrawn
    Angers, France, 49033
    Completed
    Ostrava, Czech Republic, 700 30
    Completed
    Pulawy, Poland, 24-100
    Completed
    Sneek, Netherlands, 8600 BA
    Withdrawn
    Rennes, France, 35033
    Withdrawn
    Lodz, Poland, 90-549
    Withdrawn
    Sint-Truiden, Belgium, 3800
    Withdrawn
    Toulon, France, 83100
    Completed
    Leipzig, Germany, 04105
    Withdrawn
    Moscow, Russian Federation, 119435
    Completed
    Halle Saale, Germany, 06132
    Withdrawn
    Turnhout, Belgium, 2300
    Withdrawn
    Bordeaux Cedex, France, 33076
    Withdrawn
    Gent, Belgium, 9000
    Completed
    Lutherstadt Eisleben, Germany, 06295
    Completed
    Leipzig, Germany, 04109
    Completed
    Wiecbork, Poland, 89-410
    Withdrawn
    Assebroek, Belgium, 8310
    Withdrawn
    Morriston, United Kingdom, SA6 6NL
    Completed
    Hamburg, Germany, 20253
    Completed
    Henningsdorf, Germany, 16761
    Completed
    Ganderkesee, Germany, 27777
    Completed
    Skalica, Slovakia, 909 82
    Withdrawn
    Bristol, United Kingdom, BS2 8HW
    Withdrawn
    Moscow, Russian Federation, 111020
    Completed
    Amsterdam, Netherlands, 100 AD
    Completed
    Pierre Benite, France, 69495
    Completed
    Sheffield, United Kingdom, S10 2JF
    Withdrawn
    Glasgow, United Kingdom, G20 0XA
    Withdrawn
    Bristol, United Kingdom, BS10 5NB
    Withdrawn
    Paris Cedex 12, France, 75571
    Withdrawn
    Chieti, Italy, 66100
    Completed
    Leuven, Belgium, 3000
    Completed
    Chorley, United Kingdom, PR7 7NA
    Withdrawn
    Lyon Cedex 03, France, 69437
    Completed
    Montlucon, France, 03100
    Withdrawn
    Bergamo, Italy, 24125
    Completed
    Reading, United Kingdom, RG2 7AG
    Withdrawn
    Catania, Italy, 95124
    Completed
    Apeldoorn, Netherlands, 7334 DZ
    Withdrawn
    Udine, Italy, 33100
    Withdrawn
    Brussels, Belgium, 1070
    Withdrawn
    Antwerp, Belgium, 2030
    Completed
    Edegem, Belgium, 2650
    Completed
    Bydgoszcz, Poland, 85-094
    Completed
    Uetersen, Germany, 25436
    Withdrawn
    Tours Cedex, France, 37044
    Completed
    Minsk, Belarus, 220036
    Completed
    Tilburg, Netherlands, 5022 GC
    Withdrawn
    Bari, Italy, 70124
    Withdrawn
    Enschede, Netherlands, 7511 JX
    Completed
    Usti nad Labem, Czech Republic, 400 01
    Withdrawn
    Dijon, France, 21079
    Withdrawn
    Etten-Leur, Netherlands, 4872 LA
    Completed
    Nitra, Slovakia, 949 01
    Completed
    Taunton, United Kingdom, TA1 5DA
    Withdrawn
    Florence, Italy, 50139
    Completed
    Hettstedt, Germany, 06333
    Completed
    Plzen, Czech Republic, 301 24
    Completed
    Zd'ar nad Sazavou, Czech Republic, 591 01
    Completed
    Antwerp, Belgium, 2020
    Completed
    Orleans cedex 2, France, 45067
    Completed
    Radebeul, Germany, 01445
    Completed
    Uherske Hradiste, Czech Republic, 686 08
    Completed
    Trencin, Slovakia, 911 01
    Completed
    Paris Cedex 10, France, 75020
    Completed
    Presov, Slovakia, 080 01
    Completed
    Warsaw, Poland, 02-005
    Withdrawn
    Eindhoven, Netherlands, 5623 EJ
    Withdrawn
    Kortrijk, Belgium, 8500
    Completed
    Catanzaro, Italy, 88100
    Completed
    Oxford, United Kingdom, OX3 7LJ
    Completed
    Maastricht, Netherlands, 6229 HX
    Completed
    Minsk, Belarus, 223040
    Completed
    Liverpool, United Kingdom, L22 0LG
    Withdrawn
    Turin, Italy, 10154
    Completed
    Roudnice nad Labem, Czech Republic, 413 01
    Withdrawn
    Novara, Italy, 28100
    Completed
    Northwood, United Kingdom, HA6 2RN
    Withdrawn
    Reading, United Kingdom, RG1 5AN
    Completed
    Hradec Kralove, Czech Republic, 500 02
    Completed
    Doetinchem, Netherlands, 7009 BL
    Withdrawn
    Brussels, Belgium, 1090

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?